Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
342
datasets available to search
ShareScore release 0.9.0
Dataset results
342 results for “Biliary tract”
Trastuzumab in HER2-positive Biliary Tract Cancer
ClinicalTrials.gov study NCT03613168. IPD Sharing: NO. Countries: 1. Publications: 0.
Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma
ClinicalTrials.gov study NCT06463548. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive
ClinicalTrials.gov study NCT03110328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment
ClinicalTrials.gov study NCT05170438. IPD Sharing: NO. Countries: 1. Publications: 0.
Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT05820906. IPD Sharing: NO. Countries: 1. Publications: 0.
A Safety and Efficacy Study of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract Cancer
ClinicalTrials.gov study NCT05056116. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract Carcinoma
ClinicalTrials.gov study NCT05822453. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer
ClinicalTrials.gov study NCT02558959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers
ClinicalTrials.gov study NCT02720601. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT05052099. IPD Sharing: NO. Countries: 2. Publications: 0.
GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma
ClinicalTrials.gov study NCT05668884. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety Study of Nab-Paclitaxel Combined With Cisplatin in Second or Later-Line Treatment in Advanced Biliary Tract Cancers
ClinicalTrials.gov study NCT04111380. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT06465563. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)
ClinicalTrials.gov study NCT01180153. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison Between Mechanical Intracanal (ML) Lithotripsy and Electrohydraulic Intracolangioscopic (EHL) Lithotripsy in the Treatment of Difficult Main Biliary Tract Lithiasis
ClinicalTrials.gov study NCT04970030. IPD Sharing: NO. Countries: 1. Publications: 0.
Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08）
ClinicalTrials.gov study NCT05781074. IPD Sharing: NO. Countries: 1. Publications: 0.
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
ClinicalTrials.gov study NCT06109779. IPD Sharing: YES. Countries: 21. Publications: 0.
Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
ClinicalTrials.gov study NCT01815307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
ClinicalTrials.gov study NCT06467357. IPD Sharing: YES. Countries: 27. Publications: 0.
The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer
ClinicalTrials.gov study NCT02809898. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.